Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
4.710
+0.040 (0.86%)
At close: Mar 28, 2024, 4:00 PM
4.760
+0.050 (1.06%)
After-hours: Mar 28, 2024, 4:35 PM EDT

Repare Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
111.27159.52334.43326.495.0110.93
Short-Term Investments
112.36184.427.447.5300
Cash & Cash Equivalents
223.63343.94341.87333.9295.0110.93
Cash Growth
-34.98%0.61%2.38%251.48%769.29%-
Receivables
4.54.320.654.151.980.59
Other Current Assets
15.565.728.898.481.590.53
Total Current Assets
243.69353.98351.41346.5598.5712.05
Property, Plant & Equipment
7.549.613.18.623.421.65
Other Long-Term Assets
2.670.54.211.910.70.23
Total Long-Term Assets
10.2110.117.310.534.121.88
Total Assets
253.9364.08368.72357.09102.713.93
Accounts Payable
2.40.462.32.252.131.25
Deferred Revenue
11.9555.7851.5358.018.140
Current Debt
2.42.171.720.70.630
Other Current Liabilities
22.3320.2-20.47-49.94-6.650.66
Total Current Liabilities
39.0878.6235.0911.014.251.91
Long-Term Debt
1.013.265.593.310.440
Other Long-Term Liabilities
1.732.6839.6155.938.142.53
Total Long-Term Liabilities
2.745.9445.2159.248.582.53
Total Liabilities
41.8284.5680.2970.2612.834.44
Total Debt
3.415.437.314.011.060
Debt Growth
-37.18%-25.78%82.60%276.41%--
Retained Earnings
-333.11-239.31-210.27-103.36-49.94-22.73
Comprehensive Income
0.03-0.430000
Shareholders' Equity
212.08279.52288.42286.83-46.13-22.38
Net Cash / Debt
220.22338.51334.55329.9293.9410.93
Net Cash / Debt Growth
-34.95%1.18%1.41%251.20%759.56%-
Net Cash Per Share
5.238.078.8516.4661.467.15
Working Capital
204.61275.36316.33335.5494.3310.14
Book Value Per Share
5.046.677.6314.31-30.18-14.65
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).